Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kelly

Showing results (391-400 of 411) with videos related to

Pageof 42
Sort By:
Rhinology. Supplement|May 27, 2010
European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull baseValerie J Lund, Heinz Stammberger, Piero Nicolai, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
The Lancet. Oncology|November 18, 2022
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology CommissionMark Lawler, Lynne Davies, Simon Oberst, et al.
Nature|July 19, 2023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Lawton D Murdolo, Demetra S M Chatzileontiadou, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2025
Long-COVID incidence proportion in adults and children between 2020 and 2024Hannah Mandel, Yun J Yoo, Andrea J Allen, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19Michael J Peluso, J Daniel Kelly, Scott Lu, et al.
Journal of the American Geriatrics Society|September 1, 2025
Age-Related Changes in the Clinical Picture of Long COVIDMindy J Fain, Benjamin D Horne, Leora I Horwitz, et al.
Pageof 42

Showing results (391-400 of 411) with videos related to

Sort By:
Pageof 42
Rhinology. Supplement|May 27, 2010
European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull baseValerie J Lund, Heinz Stammberger, Piero Nicolai, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
The Lancet. Oncology|November 18, 2022
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology CommissionMark Lawler, Lynne Davies, Simon Oberst, et al.
Nature|July 19, 2023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Lawton D Murdolo, Demetra S M Chatzileontiadou, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2025
Long-COVID incidence proportion in adults and children between 2020 and 2024Hannah Mandel, Yun J Yoo, Andrea J Allen, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19Michael J Peluso, J Daniel Kelly, Scott Lu, et al.
Journal of the American Geriatrics Society|September 1, 2025
Age-Related Changes in the Clinical Picture of Long COVIDMindy J Fain, Benjamin D Horne, Leora I Horwitz, et al.
Pageof 42